Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-31

Clinical Trial Update: Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immunogenicity and safety of an inactivated Hepatitis A vaccine in HIV-infected individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated hepatitis A vaccine (Hepatitis A vaccine, inactivated)

Snippet

Sponsor: LiuZhou People's Hospital | Conditions: Hepatitis A, Immunodeficiency | Phase 4 | Status: COMPLETED